The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema

Hassan Al-Dhibi; Issam H. Hamade; Ali Al-Halafi; Maan Barry; Charbel Bou Chacra; Vishali Gupta; Khalid F. Tabbara

doi:10.1155/2014/729465

The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema

Hassan Al-Dhibi, Issam H. Hamade, Ali Al-Halafi, Maan Barry, Charbel Bou Chacra, Vishali Gupta, Khalid F. Tabbara

School of Medicine

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Background/Aims: To assess the effect of intravitreal bevacizumab injection (IVBI) for the treatment of macular edema due to infectious and noninfectious uveitides. Design: Retrospective interventional case series. Methods: A chart review was performed on all the patients who were diagnosed with uveitic macular edema (UME) and received 1.25 mg of IVBI at two referral centers in Riyadh, Saudi Arabia. All included patients had their visual acuity and macular thickness analyzed at baseline and at 1 and 3 months following IVBI and any sign of reactivation was noted. Results: The mean age of patients was 41±16 years with a mean followup of 4±1 months. Ten patients had idiopathic intermediate uveitis, 9 patients had Behcet's disease, 10 had idiopathic panuveitis, and twelve patients had presumed ocular tuberculosis uveitis. Following IVBI, the mean LogMAR visual acuity improved from 0.8±0.8 at baseline to 0.4±0.5 at 1 month and 0.3±0.5 at 3 months (P

Original language	English (US)
Article number	729465
Journal	Journal of Ophthalmology
Volume	2014
DOIs	https://doi.org/10.1155/2014/729465
State	Published - 2014

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1155/2014/729465

Cite this

@article{3e69f3a800d24657a9a8c028b699994f,

title = "The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema",

abstract = "Background/Aims: To assess the effect of intravitreal bevacizumab injection (IVBI) for the treatment of macular edema due to infectious and noninfectious uveitides. Design: Retrospective interventional case series. Methods: A chart review was performed on all the patients who were diagnosed with uveitic macular edema (UME) and received 1.25 mg of IVBI at two referral centers in Riyadh, Saudi Arabia. All included patients had their visual acuity and macular thickness analyzed at baseline and at 1 and 3 months following IVBI and any sign of reactivation was noted. Results: The mean age of patients was 41±16 years with a mean followup of 4±1 months. Ten patients had idiopathic intermediate uveitis, 9 patients had Behcet's disease, 10 had idiopathic panuveitis, and twelve patients had presumed ocular tuberculosis uveitis. Following IVBI, the mean LogMAR visual acuity improved from 0.8±0.8 at baseline to 0.4±0.5 at 1 month and 0.3±0.5 at 3 months (P",

author = "Hassan Al-Dhibi and Hamade, {Issam H.} and Ali Al-Halafi and Maan Barry and Chacra, {Charbel Bou} and Vishali Gupta and Tabbara, {Khalid F.}",

year = "2014",

doi = "10.1155/2014/729465",

language = "English (US)",

volume = "2014",

journal = "Journal of Ophthalmology",

issn = "2090-004X",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema

AU - Al-Dhibi, Hassan

AU - Hamade, Issam H.

AU - Al-Halafi, Ali

AU - Barry, Maan

AU - Chacra, Charbel Bou

AU - Gupta, Vishali

AU - Tabbara, Khalid F.

PY - 2014

Y1 - 2014

N2 - Background/Aims: To assess the effect of intravitreal bevacizumab injection (IVBI) for the treatment of macular edema due to infectious and noninfectious uveitides. Design: Retrospective interventional case series. Methods: A chart review was performed on all the patients who were diagnosed with uveitic macular edema (UME) and received 1.25 mg of IVBI at two referral centers in Riyadh, Saudi Arabia. All included patients had their visual acuity and macular thickness analyzed at baseline and at 1 and 3 months following IVBI and any sign of reactivation was noted. Results: The mean age of patients was 41±16 years with a mean followup of 4±1 months. Ten patients had idiopathic intermediate uveitis, 9 patients had Behcet's disease, 10 had idiopathic panuveitis, and twelve patients had presumed ocular tuberculosis uveitis. Following IVBI, the mean LogMAR visual acuity improved from 0.8±0.8 at baseline to 0.4±0.5 at 1 month and 0.3±0.5 at 3 months (P

AB - Background/Aims: To assess the effect of intravitreal bevacizumab injection (IVBI) for the treatment of macular edema due to infectious and noninfectious uveitides. Design: Retrospective interventional case series. Methods: A chart review was performed on all the patients who were diagnosed with uveitic macular edema (UME) and received 1.25 mg of IVBI at two referral centers in Riyadh, Saudi Arabia. All included patients had their visual acuity and macular thickness analyzed at baseline and at 1 and 3 months following IVBI and any sign of reactivation was noted. Results: The mean age of patients was 41±16 years with a mean followup of 4±1 months. Ten patients had idiopathic intermediate uveitis, 9 patients had Behcet's disease, 10 had idiopathic panuveitis, and twelve patients had presumed ocular tuberculosis uveitis. Following IVBI, the mean LogMAR visual acuity improved from 0.8±0.8 at baseline to 0.4±0.5 at 1 month and 0.3±0.5 at 3 months (P

UR - http://www.scopus.com/inward/record.url?scp=84936856352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936856352&partnerID=8YFLogxK

U2 - 10.1155/2014/729465

DO - 10.1155/2014/729465

M3 - Article

C2 - 25136452

AN - SCOPUS:84936856352

SN - 2090-004X

VL - 2014

JO - Journal of Ophthalmology

JF - Journal of Ophthalmology

M1 - 729465

ER -

The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this